CCNY IUSL scientists study optical biopsy tool that detects disease in seconds

January 24, 2018

Today, it is standard practice to detect many diseases through MRIs, PETs, X-rays, or CAT scans. But all of these medical imaging methods include some risk of radiation and take hours - if not days - to get results. Most importantly, the level of information they provide is lacking because it is not at the molecular level.

Raman spectroscopy, a tool previously used to provide molecular information in science, is now being used in medicine and biomedicine to provide an optical biopsy that offers more detailed, faster detection. This novel, less invasive way of detecting disease using light salient properties was employed for the first time in 1991 to identify a fingerprint for cancer in tissue by a team led by Robert Alfano, a Distinguished Professor of Science and Engineering at The City College of New York, and director of The Institute for Ultrafast Spectroscopy and Lasers (IUSL) of the City University of New York at City College.

A recent IUSL paper published in the Journal of Photochemistry and Photobiology reports how research in this area continues to advance. It shows how Resonance Raman spectroscopy in tissue (specifically investigating carotene using different visible lasers) can detect vibrations when an exciting laser enters an absorption of a molecule. The paper's authors include: visiting scientists Luyao Lua of Wenzhou Medical University, and Lingyan Shi of Columbia University, along with City College IUSL Research Associate Jeff Secor, and Robert Alfano.

Alfano states "Resonant Raman using the laser pointer 532 nm has become an e?cient tool for investigating molecular components in tissues and cells, providing more detailed information and a way to detect diseases like skin cancer, brain cancer, or atherosclerosis - in mere seconds."
-end-


City College of New York

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.